PPARGC1A and myopathy: A statin-induced decrease in PGC1α could help to explain reports that statin myopathy is associated with a reduction in mitochondrial content [14,23,30–32,60] and an increase in the activation of atrophy genes and muscle atrophy [14,34,35].